Chemotherapy Drugs Market Analysis By Indication(Oncology/Cancer, Bone Marrow Diseases, Immune System Disorders), By Type(Alkylating Agents, Anti-metabolites, Plant Alkaloids and Terpenoids, Podophyllotoxin, Taxanes, Topoisomerase Inhibitor, Anti-Tumour Antibiotics, Hormones, Monoclonal Antibodies), By Dosage Forms(Capsule, Tablets, Injections), By Route of Administration(Oral, Parenteral, Intravenous, Subcutaneous), By End Users(Hospitals, Specialty Clinics, Homecare), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Forecast By 2030
- PUBLISHED ON
- 2024-07-10
- NO OF PAGES
- 215
- CATEGORY
- Healthcare & Life Sciences
Market Overview
Chemotherapy Drugs Market size was valued at USD 155.0 billion in 2021 and is projected to reach around USD 330.0 billion in 2030 exhibiting a CAGR of 7.5% in the forecasted period.
The rising prevalence of cancer, increasing healthcare expenditure are driving the chemotherapy drugs are expected to increase the market growth. On the other hand, high cost associated with the chemotherapy drugs, side effects of chemotherapy drugs are some restraining factors limiting the growth.
The increasing prevalence of cancer is anticipated to improve the chemotherapy drug market's growth rate. Cancer is the maximum cause of mortality globally, as per the World Health Organization (WHO), accounting for nearly 10 million deaths in 2020, or about one in every six deaths. About 400 000 children are diagnosed with cancer each year.
Cervical cancer is the most common cancer in 23 of the world's nations. Chemotherapy utilizes either site-specific or intravenous drug delivery. In spite of advances in cancer treatment technology, the disease still dues the lives of up to 8 million people per year.
Chemotherapy or anti-cancer drugs are elements that can denature cancer cells by faltering their proliferation. Recently, in May 2022, Gland Pharma launched the Bortezomib for Injection in US.
Bortezomib for injection is engaged for treating certain types of cancer containing multiple myeloma and mantle cell lymphoma. The chemotherapy drugs market is anticipated to boost during the forecasted period.
Since the emergence in December 2019, the COVID-19 virus has spread to each country on the planet, stimulating the World Health Organization (WHO) to state it a public health emergency.
Type Insights
By type, the chemotherapy drugs market is bifurcated into alkylating agents, anti-metabolites, plant alkaloids and terpenoids, podophyllotoxin, taxanes, topoisomerase inhibitor, anti-tumour antibiotics, hormones, monoclonal antibodies, and others.
Indication Insights
In terms of indication, the chemotherapy drugs market is segmented into oncology/cancer, bone marrow diseases, immune system disorders, and others.
Region Insights
In 2021, North America dominates the chemotherapy drug market due to the presence of major manufacture of the product and growing geriatric population in this region. Moreover, high research and development expenditure and presence of skilled experts will further boost the market’s growth rate in this region.
Asia-Pacific is anticipated to propel during the forecast period owing to grown government awareness programs and increasing healthcare expenditure in this region. Also, rising number of generic drugs will further cushion the market’s growth rate in this region.
Key Companies Insights
To stay competitive in the global market, players are using new strategies such as new product development, mergers and acquisitions, joint ventures, and geographic expansions. Some of the key players operating in the global chemotherapy drugs market include:
• Mylan N.V.
• Merck & Co., Inc.
• Allergan
• AstraZeneca
• AbbVie Inc.
• Bayer AG
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Fresenius Kabi AG
• Amneal Pharmaceuticals LLC
• LEO Pharma A/S
• Johnson & Johnson Private Limited
• F. Hoffmann-La Roche Ltd
• Sanofi
• Amgen Inc.
• Eli Lilly & Company
• Novartis AG
• Other players
Some of the Recent Developments
• In April 2022, Sierra Oncology was acquired by GSK for $1.9 billion.
• In August 2022, the Indian Drugs Controller General permitted AstraZeneca India authorization to market Lynparza, a medication used to treat breast cancer.
Segments
By Indication
• Oncology/Cancer
• Bone Marrow Diseases
• Immune System Disorders
• Others
By Type
• Alkylating Agents
• Anti-metabolites
• Plant Alkaloids and Terpenoids
• Podophyllotoxin
• Taxanes
• Topoisomerase Inhibitor
• Anti-Tumour Antibiotics
• Hormones
• Monoclonal Antibodies
• Others
By Dosage Forms
• Capsule
• Tablets
• Injections
• Others
By Route of Administration
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Others
By End Users
• Hospitals
• Specialty Clinics
• Homecare
• Others
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
Market Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period.
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size and growth projections?
The global chemotherapy drugs market size was valued at USD 155.0 billion in 2021 and is projected to reach around USD 330.0 billion in 2030 exhibiting a CAGR of 7.5% in the forecasted period.
What are the drivers shaping various markets?
The increasing prevalence of cancer is anticipated to improve the chemotherapy drug market's growth rate.
Who are the key competitors of market Players?
Some of the major players operating within the market are Mylan N.V., Merck & Co., Inc., Allergan, AstraZeneca, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Fresenius Kabi AG, Amneal Pharmaceuticals LLC, LEO Pharma A/S, Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd, Sanofi, Amgen Inc., Eli Lilly & Company, Novartis AG, Other players.
What are the top performing segments, and countries / regions of each of the markets?
The countries covered in the regional analysis of the Global Chemotherapy Drugs market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI